There have been no open-market insider trades at ACELYRIN, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at ACELYRIN, Inc. in the last 12 months.
Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | Kim Mina | CEO | Sell | 17,986 | $2.74 | $49K | SEC |
| Mar 19, 2025 | Murugan Amar | Executive Officer | Sell | 3,913 | $2.74 | $11K | SEC |
| Mar 19, 2025 | Mpofu Shephard | Executive Officer | Sell | 3,211 | $2.74 | $9K | SEC |
| Jul 19, 2024 | Becker Daniel J. | Director | Sell | 1 | $6.86 | $7 | SEC |
| Apr 3, 2024 | Lin Shao-Lee | CEO | Sell | 9,961 | $6.63 | $66K | SEC |
| Feb 22, 2024 | Lin Shao-Lee | CEO | Sell | 15,701 | $7.60 | $119K | SEC |
| Jan 4, 2024 | Lin Shao-Lee | CEO | Sell | 10,691 | $7.41 | $79K | SEC |
| May 11, 2023 | SEIDENBERG BETH C | Director | Buy | 60,000 | $18.00 | $1.1M | SEC |
| May 11, 2023 | Svoronos Dawn | Director | Buy | 15,000 | $18.00 | $270K | SEC |
| May 11, 2023 | Gosebruch Henry O | Director | Buy | 50,000 | $18.00 | $900K | SEC |
| May 11, 2023 | Becker Daniel J. | Director | Buy | 3,000 | $18.00 | $54K | SEC |
| May 11, 2023 | Oyston Ronald | Executive Officer | Buy | 1,000 | $18.00 | $18K | SEC |
| May 11, 2023 | Kim Mina | Executive Officer | Buy | 5,000 | $18.00 | $90K | SEC |
| May 11, 2023 | Dier Mardi | CFO | Buy | 875 | $18.00 | $16K | SEC |
| May 11, 2023 | Dier Mardi | CFO | Buy | 875 | $18.00 | $16K | SEC |
There were no open-market insider trades in SLRN in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in SLRN were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).